Debomoy K. Lahiri - Publications

Medical Neurobiology Indiana University, Bloomington, Bloomington, IN, United States 
Neuroscience Biology, Cell Biology, Molecular Biology

286 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.


Year Citation  Score
2021 Perez FP, Maloney B, Chopra N, Morisaki JJ, Lahiri DK. Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures. Scientific Reports. 11: 621. PMID 33436686 DOI: 10.1038/s41598-020-77808-2  0.4
2020 Lahiri DK, Maloney B, Wang R, Sokol DK, Rogers JT, Westmark CJ. How autism and Alzheimer's disease are TrAPPed. Molecular Psychiatry. PMID 33184495 DOI: 10.1038/s41380-020-00928-8  0.4
2020 Westmark CJ, Maloney B, Alisch RS, Sokol DK, Lahiri DK. FMRP Regulates the Nuclear Export of Adam9 and Psen1 mRNAs: Secondary Analysis of an N-Methyladenosine Dataset. Scientific Reports. 10: 10781. PMID 32612155 DOI: 10.1038/s41598-020-66394-y  0.4
2020 Ray B, Maloney B, Sambamurti K, Karnati HK, Nelson PT, Greig NH, Lahiri DK. Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease. Translational Psychiatry. 10: 81. PMID 32123156 DOI: 10.1038/s41398-020-0757-2  0.44
2020 Ray B, Maloney B, Sambamurti K, Karnati HK, Nelson PT, Greig NH, Lahiri DK. Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease. Translational Psychiatry. 10: 47. PMID 32066688 DOI: 10.1038/s41398-020-0709-x  0.44
2020 Chopra N, Wang R, Maloney B, Nho K, Beck JS, Pourshafie N, Niculescu A, Saykin AJ, Rinaldi C, Counts SE, Lahiri DK. MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties. Molecular Psychiatry. PMID 31942037 DOI: 10.1038/s41380-019-0610-2  0.4
2019 Maloney B, Balaraman Y, Liu Y, Chopra N, Edenberg HJ, Kelsoe J, Nurnberger JI, Lahiri DK. Lithium alters expression of RNAs in a type-specific manner in differentiated human neuroblastoma neuronal cultures, including specific genes involved in Alzheimer's disease. Scientific Reports. 9: 18261. PMID 31797941 DOI: 10.1038/s41598-019-54076-3  0.4
2019 Konar A, Gupta R, Shukla RK, Maloney B, Khanna VK, Wadhwa R, Lahiri DK, Thakur MK. M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania somnifera. Scientific Reports. 9: 13990. PMID 31570736 DOI: 10.1038/s41598-019-48238-6  0.4
2019 Lahiri DK, Maloney B, Wang R. APPealing for a role in cellular iron efflux. The Journal of Biological Chemistry. 294: 9365. PMID 31201240 DOI: 10.1074/jbc.L119.009216  0.4
2019 Sokol DK, Maloney B, Westmark CJ, Lahiri DK. Novel Contribution of Secreted Amyloid-β Precursor Protein to White Matter Brain Enlargement in Autism Spectrum Disorder. Frontiers in Psychiatry. 10: 165. PMID 31024350 DOI: 10.3389/fpsyt.2019.00165  0.4
2019 Duffy KB, Ray B, Lahiri DK, Tilmont EM, Tinkler GP, Herbert RL, Greig NH, Ingram DK, Ottinger MA, Mattison JA. Effects of Reducing Norepinephrine Levels via DSP4 Treatment on Amyloid-β Pathology in Female Rhesus Macaques (Macaca Mulatta). Journal of Alzheimer's Disease : Jad. PMID 30689563 DOI: 10.3233/JAD-180487  0.44
2018 Long JM, Maloney B, Rogers JT, Lahiri DK. Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5'-untranslated region: Implications in Alzheimer's disease. Molecular Psychiatry. PMID 30470799 DOI: 10.1038/s41380-018-0266-3  0.88
2018 Venkataramani V, Doeppner TR, Willkommen D, Cahill CM, Xin Y, Ye G, Liu Y, Southon A, Aron A, Au-Yeung HY, Huang X, Lahiri DK, Wang F, Bush AI, Wulf GG, et al. Manganese causes neurotoxic iron accumulation via translational repression of Amyloid Precursor Protein (APP) and H-Ferritin. Journal of Neurochemistry. PMID 30152072 DOI: 10.1111/jnc.14580  0.4
2018 Maloney B, Bayon BL, Zawia NH, Lahiri DK. Latent consequences of early-life lead (Pb) exposure and the future: Addressing the Pb Crisis. Neurotoxicology. PMID 29981765 DOI: 10.1016/j.neuro.2018.06.016  0.4
2018 Konar A, Kumar A, Maloney B, Lahiri DK, Thakur MK. A serine protease KLK8 emerges as a regulator of regulators in memory: Microtubule protein dependent neuronal morphology and PKA-CREB signaling. Scientific Reports. 8: 9928. PMID 29967374 DOI: 10.1038/s41598-018-27640-6  0.4
2017 Lahiri DK, Maloney B, Greig NH. Are pulmonary fibrosis and Alzheimer's disease linked? Shared dysregulation of two miRNA species and downstream pathways accompany both disorders. The Journal of Biological Chemistry. 292: 20353. PMID 29222197 DOI: 10.1074/jbc.L117.000502  0.4
2017 Lahiri DK, Maloney B, Sambamurti K. When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's author. Gene. PMID 28888578 DOI: 10.1016/j.gene.2017.08.011  0.4
2017 Lahiri DK, Thakur MK, Maloney B. A cardinal sin when researching neuropsin: Thou shalt validate antibodies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28732191 DOI: 10.1016/j.jalz.2016.12.016  0.4
2016 Srinivasan M, Bayon B, Chopra N, Lahiri DK. Novel Nuclear Factor-KappaB Targeting Peptide Suppresses β-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal Cells. Plos One. 11: e0160314. PMID 27764084 DOI: 10.1371/journal.pone.0160314  0.4
2016 Erickson CA, Ray B, Wink LK, Bayon BL, Pedapati EV, Shaffer R, Schaefer TL, Lahiri DK. Initial analysis of peripheral lymphocytic extracellular signal related kinase activation in autism. Journal of Psychiatric Research. 84: 153-160. PMID 27743527 DOI: 10.1016/j.jpsychires.2016.09.003  0.88
2016 Westmark CJ, Sokol DK, Maloney B, Lahiri DK. Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism. Molecular Psychiatry. PMID 27573877 DOI: 10.1038/mp.2016.134  0.4
2016 Erickson CA, Wink LK, Baindu B, Ray B, Schaefer TL, Pedapati EV, Lahiri D. Analysis of peripheral amyloid precursor protein in Angelman Syndrome. American Journal of Medical Genetics. Part A. PMID 27327493 DOI: 10.1002/ajmg.a.37811  0.88
2016 Maloney B, Lahiri DK. Epigenetics of dementia: understanding the disease as a transformation rather than a state. The Lancet. Neurology. 15: 760-74. PMID 27302240 DOI: 10.1016/S1474-4422(16)00065-X  0.4
2016 Ray B, Sokol DK, Maloney B, Lahiri DK. Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue. Scientific Reports. 6: 26052. PMID 27212113 DOI: 10.1038/srep26052  0.44
2016 Lahiri DK, Maloney B, Bayon BL, Chopra N, White FA, Greig NH, Nurnberger JI. Transgenerational latent early-life associated regulation unites environment and genetics across generations. Epigenomics. PMID 26950428 DOI: 10.2217/epi.15.117  0.88
2016 Shah K, Lahiri DK. A Tale of the Good and Bad: Remodeling of the Microtubule Network in the Brain by Cdk5. Molecular Neurobiology. PMID 26944284 DOI: 10.1007/s12035-016-9792-7  0.88
2016 Huang Y, Lahiri DK. Translational Alzheimer’s disease research Current Alzheimer Research. 13: 214.  0.88
2015 Kim E, Woo MS, Qin L, Ma T, Beltran CD, Bao Y, Bailey JA, Corbett D, Ratan RR, Lahiri DK, Cho S. Daidzein Augments Cholesterol Homeostasis via ApoE to Promote Functional Recovery in Chronic Stroke. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 15113-26. PMID 26558782 DOI: 10.1523/JNEUROSCI.2890-15.2015  0.88
2015 Sarkar S, Raymick J, Ray B, Lahiri DK, Paule MG, Schmued L. Oral Administration of Thioflavin T Prevents Beta Amyloid Plaque Formation in Double Transgenic AD Mice. Current Alzheimer Research. 12: 837-46. PMID 26510980  0.88
2015 Banik A, Brown RE, Bamburg J, Lahiri DK, Khurana D, Friedland RP, Chen W, Ding Y, Mudher A, Padjen AL, Mukaetova-Ladinska E, Ihara M, Srivastava S, Padma Srivastava MV, Masters CL, et al. Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?1. Journal of Alzheimer's Disease : Jad. 47: 815-43. PMID 26401762 DOI: 10.3233/JAD-150136  0.88
2015 Lahiri DK. What is aging for? That remains the question. Current Aging Science. 8: 1. PMID 26251866  0.88
2015 Becker RE, Seeman MV, Greig NH, Lahiri DK. What can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general? The Lancet. Psychiatry. 2: 756-64. PMID 26249306 DOI: 10.1016/S2215-0366(15)00214-X  0.88
2015 Lahiri DK. View of excellent ROAD from the CAR. Current Alzheimer Research. 12: 96-9. PMID 25832502  0.88
2015 Srinivasan M, Lahiri DK. Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis. Expert Opinion On Therapeutic Targets. 19: 471-87. PMID 25652642 DOI: 10.1517/14728222.2014.989834  0.88
2015 Baranello RJ, Bharani KL, Padmaraju V, Chopra N, Lahiri DK, Greig NH, Pappolla MA, Sambamurti K. Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease. Current Alzheimer Research. 12: 32-46. PMID 25523424  0.88
2015 Wink LK, Fitzpatrick S, Shaffer R, Melnyk S, Begtrup AH, Fox E, Schaefer TL, Mathieu-Frasier L, Ray B, Lahiri D, Horn PA, Erickson CA. The neurobehavioral and molecular phenotype of Angelman syndrome American Journal of Medical Genetics, Part A. DOI: 10.1002/ajmg.a.37254  0.88
2015 Sarkar S, Raymick J, Ray B, Lahiri DK, Paule MG, Schmued L. Oral administration of thioflavin t prevents beta amyloid plaque formation in double transgenic ad mice Current Alzheimer Research. 12: 837-846.  0.88
2014 Srinivasan M, Blackburn C, Lahiri DK. Functional characterization of a competitive peptide antagonist of p65 in human macrophage-like cells suggests therapeutic potential for chronic inflammation. Drug Design, Development and Therapy. 8: 2409-21. PMID 25584020 DOI: 10.2147/DDDT.S59722  0.88
2014 Erickson CA, Ray B, Maloney B, Wink LK, Bowers K, Schaefer TL, McDougle CJ, Sokol DK, Lahiri DK. Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker. Journal of Psychiatric Research. 59: 220-8. PMID 25300441 DOI: 10.1016/j.jpsychires.2014.07.011  0.88
2014 Ray B, Chopra N, Long JM, Lahiri DK. Human primary mixed brain cultures: preparation, differentiation, characterization and application to neuroscience research. Molecular Brain. 7: 63. PMID 25223359 DOI: 10.1186/s13041-014-0063-0  0.88
2014 Counts SE, Lahiri DK. Overview of immunotherapy in Alzheimer's disease (AD) and mechanisms of IVIG neuroprotection in preclinical models of AD. Current Alzheimer Research. 11: 623-5. PMID 25156573 DOI: 10.2174/156720501107140815102453  0.88
2014 Greig NH, Sambamurti K, Lahiri DK, Becker RE. Amyloid-β precursor protein synthesis inhibitors for Alzheimer's disease treatment. Annals of Neurology. 76: 629-30. PMID 25146731 DOI: 10.1002/ana.24254  0.88
2014 Lahiri DK, Ray B. Intravenous immunoglobulin treatment preserves and protects primary rat hippocampal neurons and primary human brain cultures against oxidative insults. Current Alzheimer Research. 11: 645-54. PMID 25115544  0.88
2014 Modgil S, Lahiri DK, Sharma VL, Anand A. Role of early life exposure and environment on neurodegeneration: implications on brain disorders. Translational Neurodegeneration. 3: 9. PMID 24847438 DOI: 10.1186/2047-9158-3-9  0.88
2014 Counts SE, Ray B, Mufson EJ, Perez SE, He B, Lahiri DK. Intravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer's disease. Journal of Clinical Immunology. 34: S80-5. PMID 24760109 DOI: 10.1007/s10875-014-0020-9  0.88
2014 Leitch CC, Lodh S, Prieto-Echagüe V, Badano JL, Zaghloul NA. Basal body proteins regulate Notch signaling through endosomal trafficking. Journal of Cell Science. 127: 2407-19. PMID 24681783 DOI: 10.1242/jcs.130344  0.88
2014 Greig NH, Lahiri DK. Advances in understanding Alzheimer's disease, and the contributions of current Alzheimer research: ten years on and beyond. Current Alzheimer Research. 11: 107-9. PMID 24661146 DOI: 10.2174/156720501102140313162901  0.88
2014 Zhang YH, Mann D, Raymick J, Sarkar S, Paule MG, Lahiri DK, Dumas M, Bell-Cohen A, Schmued LC. K114 inhibits A-beta aggregation and inflammation in vitro and in vivo in AD/Tg mice. Current Alzheimer Research. 11: 299-308. PMID 24552157 DOI: 10.2174/1567205011666140220125324  0.88
2014 Lahiri DK, Maloney B, Long JM, Greig NH. Lessons from a BACE1 inhibitor trial: off-site but not off base. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S411-9. PMID 24530026 DOI: 10.1016/j.jalz.2013.11.004  0.88
2014 Greig NH, Tweedie D, Rachmany L, Li Y, Rubovitch V, Schreiber S, Chiang YH, Hoffer BJ, Miller J, Lahiri DK, Sambamurti K, Becker RE, Pick CG. Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S62-75. PMID 24529527 DOI: 10.1016/j.jalz.2013.12.011  0.88
2014 Reale M, Di Nicola M, Velluto L, D'Angelo C, Costantini E, Lahiri DK, Kamal MA, Yu QS, Greig NH. Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway. Current Alzheimer Research. 11: 608-22. PMID 24359497 DOI: 10.2174/1567205010666131212113218  0.88
2014 Long JM, Ray B, Lahiri DK. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects. The Journal of Biological Chemistry. 289: 5184-98. PMID 24352696 DOI: 10.1074/jbc.M113.518241  0.88
2014 Perez FP, Bose D, Maloney B, Nho K, Shah K, Lahiri DK. Late-onset Alzheimer's disease, heating up and foxed by several proteins: pathomolecular effects of the aging process. Journal of Alzheimer's Disease : Jad. 40: 1-17. PMID 24326519 DOI: 10.3233/JAD-131544  0.88
2013 Bandyopadhyay S, Cahill C, Balleidier A, Huang C, Lahiri DK, Huang X, Rogers JT. Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease. Plos One. 8: e65978. PMID 23935819 DOI: 10.1371/journal.pone.0065978  0.88
2013 Lahiri DK, Sokol DK, Erickson C, Ray B, Ho CY, Maloney B. Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathway. Frontiers in Cellular Neuroscience. 7: 94. PMID 23801940 DOI: 10.3389/fncel.2013.00094  0.88
2013 Zhang YH, Raymick J, Sarkar S, Lahiri DK, Ray B, Holtzman D, Dumas M, Schmued LC. Efficacy and toxicity of clioquinol treatment and A-beta42 inoculation in the APP/PSI mouse model of Alzheimer's disease. Current Alzheimer Research. 10: 494-506. PMID 23627708 DOI: 10.2174/1567205011310050005  0.88
2013 Erickson CA, Wink LK, Ray B, Early MC, Stiegelmeyer E, Mathieu-Frasier L, Patrick V, Lahiri DK, McDougle CJ. Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome. Psychopharmacology. 228: 75-84. PMID 23436129 DOI: 10.1007/s00213-013-3022-z  0.88
2013 Lahiri DK, Maloney B, Rogers JT, Ge YW. PuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer's amyloid-β precursor protein via a tissue-specific proximal regulatory element (PRE). Bmc Genomics. 14: 68. PMID 23368879 DOI: 10.1186/1471-2164-14-68  0.88
2013 Lahiri DK. Progress of "Current Alzheimer Research" and future direction. Current Alzheimer Research. 10: 1-3. PMID 23368431 DOI: 10.2174/1567205011310010001  0.88
2013 Yu QS, Reale M, Kamal MA, Holloway HW, Luo W, Sambamurti K, Ray B, Lahiri DK, Rogers JT, Greig NH. Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholinergic action. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 12: 117-28. PMID 23360256 DOI: 10.2174/1871523011312020003  0.88
2013 Ding ZM, Rodd ZA, Engleman EA, Bailey JA, Lahiri DK, McBride WJ. Alcohol drinking and deprivation alter basal extracellular glutamate concentrations and clearance in the mesolimbic system of alcohol-preferring (P) rats. Addiction Biology. 18: 297-306. PMID 23240885 DOI: 10.1111/adb.12018  0.88
2013 Lahiri DK, Ray B. Abnormal cerebrospinal fluid (CSF) dynamics in Alzheimer's disease and normal pressure hydrocephalus: CSF-amyloid β precursor protein metabolites as possible biomarkers. European Journal of Neurology. 20: 211-3. PMID 22934632 DOI: 10.1111/j.1468-1331.2012.03832.x  0.88
2012 Holohan KN, Lahiri DK, Schneider BP, Foroud T, Saykin AJ. Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways. Frontiers in Genetics. 3: 323. PMID 23335942 DOI: 10.3389/fgene.2012.00323  0.88
2012 Lahiri DK, Maloney B. Gene × environment interaction by a longitudinal epigenome-wide association study (LEWAS) overcomes limitations of genome-wide association study (GWAS). Epigenomics. 4: 685-99. PMID 23244313 DOI: 10.2217/epi.12.60  0.88
2012 Lahiri DK. Prions: a piece of the puzzle? Science (New York, N.Y.). 337: 1172. PMID 22955815 DOI: 10.1126/science.337.6099.1172-a  0.88
2012 Ray B, Bailey JA, Simon JR, Lahiri DK. High-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity in neuronal cultures for mechanistic and drug discovery studies. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 7.23. PMID 22752895 DOI: 10.1002/0471142301.ns0723s60  0.88
2012 Long JM, Ray B, Lahiri DK. MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients. The Journal of Biological Chemistry. 287: 31298-310. PMID 22733824 DOI: 10.1074/jbc.M112.366336  0.88
2012 Tweedie D, Ferguson RA, Fishman K, Frankola KA, Van Praag H, Holloway HW, Luo W, Li Y, Caracciolo L, Russo I, Barlati S, Ray B, Lahiri DK, Bosetti F, Greig NH, et al. Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease. Journal of Neuroinflammation. 9: 106. PMID 22642825 DOI: 10.1186/1742-2094-9-106  0.88
2012 Bailey JA, Lahiri DK. Chromatographic separation of reaction products from the choline acetyltransferase and carnitine acetyltransferase assay: differential ChAT and CrAT activity in brain extracts from Alzheimer's disease versus controls. Journal of Neurochemistry. 122: 672-80. PMID 22607230 DOI: 10.1111/j.1471-4159.2012.07793.x  0.88
2012 Lahiri DK, Maloney B. The "LEARn" (latent early-life associated regulation) model: an epigenetic pathway linking metabolic and cognitive disorders. Journal of Alzheimer's Disease : Jad. 30: S15-30. PMID 22555376 DOI: 10.3233/JAD-2012-120373  0.88
2012 Li Y, Chigurupati S, Holloway HW, Mughal M, Tweedie D, Bruestle DA, Mattson MP, Wang Y, Harvey BK, Ray B, Lahiri DK, Greig NH. Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis. Plos One. 7: e32008. PMID 22384126 DOI: 10.1371/journal.pone.0032008  0.88
2012 Zawia NH, Lahiri DK. Epigenetics: a paradigm shift in understanding Alzheimer's disease. Current Alzheimer Research. 9: 525-6. PMID 22364524  0.88
2012 Maloney B, Lahiri DK. Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's disease. Gene. 501: 63-78. PMID 22310385 DOI: 10.1016/j.gene.2012.01.049  0.88
2012 Maloney B, Sambamurti K, Zawia N, Lahiri DK. Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model. Current Alzheimer Research. 9: 589-99. PMID 22300406  0.88
2012 Bihaqi SW, Schumacher A, Maloney B, Lahiri DK, Zawia NH. Do epigenetic pathways initiate late onset Alzheimer disease (LOAD): towards a new paradigm. Current Alzheimer Research. 9: 574-88. PMID 22300405  0.88
2012 Long JM, Lahiri DK. Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders. Experimental Neurology. 235: 402-18. PMID 22245616 DOI: 10.1016/j.expneurol.2011.12.043  0.88
2012 Olivares D, Deshpande VK, Shi Y, Lahiri DK, Greig NH, Rogers JT, Huang X. N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease. Current Alzheimer Research. 9: 746-58. PMID 21875407  0.88
2012 Lahiri DK. Brain aging: Influence of early-life events on late-life brain disorders Brain Aging and Therapeutic Interventions. 67-78. DOI: 10.1007/978-94-007-5237-5_5  0.88
2011 Bailey JA, Ray B, Greig NH, Lahiri DK. Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons. Plos One. 6: e21954. PMID 21799757 DOI: 10.1371/journal.pone.0021954  0.88
2011 Ray B, Long JM, Sokol DK, Lahiri DK. Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker. Plos One. 6: e20405. PMID 21731612 DOI: 10.1371/journal.pone.0020405  0.88
2011 Ray B, Chauhan NB, Lahiri DK. The "aged garlic extract:" (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD). Current Medicinal Chemistry. 18: 3306-13. PMID 21728972 DOI: 10.2174/092986711796504664  0.88
2011 Long JM, Lahiri DK. Current drug targets for modulating Alzheimer's amyloid precursor protein: role of specific micro-RNA species. Current Medicinal Chemistry. 18: 3314-21. PMID 21728971 DOI: 10.2174/092986711796504592  0.88
2011 Bailey JA, Maloney B, Ge YW, Lahiri DK. Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis. Gene. 488: 13-22. PMID 21708232 DOI: 10.1016/j.gene.2011.06.017  0.88
2011 Maloney B, Lahiri DK. The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motif. Gene. 488: 1-12. PMID 21699964 DOI: 10.1016/j.gene.2011.06.004  0.88
2011 Bisht S, Khan MA, Bekhit M, Bai H, Cornish T, Mizuma M, Rudek MA, Zhao M, Maitra A, Ray B, Lahiri D, Maitra A, Anders RA. A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Laboratory Investigation; a Journal of Technical Methods and Pathology. 91: 1383-95. PMID 21691262 DOI: 10.1038/labinvest.2011.86  0.88
2011 Luo W, Yu QS, Salcedo I, Holloway HW, Lahiri DK, Brossi A, Tweedie D, Greig NH. Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity. Bioorganic & Medicinal Chemistry. 19: 3965-72. PMID 21658960 DOI: 10.1016/j.bmc.2011.05.029  0.88
2011 Sokol DK, Maloney B, Long JM, Ray B, Lahiri DK. Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology. 76: 1344-52. PMID 21482951 DOI: 10.1212/WNL.0b013e3182166dc7  0.88
2011 Ray B, Gaskins DL, Sajdyk TJ, Spence JP, Fitz SD, Shekhar A, Lahiri DK. Restraint stress and repeated corticotrophin-releasing factor receptor activation in the amygdala both increase amyloid-β precursor protein and amyloid-β peptide but have divergent effects on brain-derived neurotrophic factor and pre-synaptic proteins in the prefrontal cortex of rats. Neuroscience. 184: 139-50. PMID 21477639 DOI: 10.1016/j.neuroscience.2011.03.067  0.88
2011 Sambamurti K, Greig NH, Utsuki T, Barnwell EL, Sharma E, Mazell C, Bhat NR, Kindy MS, Lahiri DK, Pappolla MA. Targets for AD treatment: conflicting messages from γ-secretase inhibitors. Journal of Neurochemistry. 117: 359-74. PMID 21320126 DOI: 10.1111/j.1471-4159.2011.07213.x  0.88
2011 Lahiri DK. Application of a multidisciplinary approach to Alzheimer's disease to develop novel drug targets by integrating biomarkers, imaging, genetic and molecular strategies. Current Alzheimer Research. 8: 1-3. PMID 21265731 DOI: 10.2174/156720511794604534  0.88
2011 Lahiri DK. An integrated approach to genome studies. Science (New York, N.Y.). 331: 147. PMID 21233370 DOI: 10.1126/science.331.6014.147-a  0.88
2011 Rogers JT, Mikkilineni S, Cantuti-Castelvetri I, Smith DH, Huang X, Bandyopadhyay S, Cahill CM, Maccecchini ML, Lahiri DK, Greig NH. The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 493-507. PMID 21221670 DOI: 10.1007/s00702-010-0513-5  0.88
2011 Long JM, Lahiri DK. MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed. Biochemical and Biophysical Research Communications. 404: 889-95. PMID 21172309 DOI: 10.1016/j.bbrc.2010.12.053  0.88
2011 Ray B, Chauhan NB, Lahiri DK. Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse model. Journal of Neurochemistry. 117: 388-402. PMID 21166677 DOI: 10.1111/j.1471-4159.2010.07145.x  0.88
2011 Ray B, Bisht S, Maitra A, Maitra A, Lahiri DK. Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 23: 61-77. PMID 20930270 DOI: 10.3233/JAD-2010-101374  0.88
2011 Ray B, Reyes PF, Lahiri DK. Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau. Journal of Psychiatric Research. 45: 539-47. PMID 20828718 DOI: 10.1016/j.jpsychires.2010.07.011  0.88
2011 Kurian SM, Le-Niculescu H, Patel SD, Bertram D, Davis J, Dike C, Yehyawi N, Lysaker P, Dustin J, Caligiuri M, Lohr J, Lahiri DK, Nurnberger JI, Faraone SV, Geyer MA, et al. Identification of blood biomarkers for psychosis using convergent functional genomics. Molecular Psychiatry. 16: 37-58. PMID 19935739 DOI: 10.1038/mp.2009.117  0.88
2010 Lahiri DK. 'Current Alzheimer research' helps accelerate the progress of the field. Current Alzheimer Research. 7: 1-2. PMID 21418013 DOI: 10.2174/156720510790274419  0.88
2010 Bandyopadhyay S, Huang X, Lahiri DK, Rogers JT. Novel drug targets based on metallobiology of Alzheimer's disease. Expert Opinion On Therapeutic Targets. 14: 1177-97. PMID 20942746 DOI: 10.1517/14728222.2010.525352  0.88
2010 Liu D, Pitta M, Lee JH, Ray B, Lahiri DK, Furukawa K, Mughal M, Jiang H, Villarreal J, Cutler RG, Greig NH, Mattson MP. The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 22: 443-57. PMID 20847430 DOI: 10.3233/JAD-2010-101017  0.88
2010 Yu QS, Holloway HW, Luo W, Lahiri DK, Brossi A, Greig NH. Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. Bioorganic & Medicinal Chemistry. 18: 4687-93. PMID 20627738 DOI: 10.1016/j.bmc.2010.05.022  0.88
2010 Bondy SC, Li H, Zhou J, Wu M, Bailey JA, Lahiri DK. Melatonin alters age-related changes in transcription factors and kinase activation. Neurochemical Research. 35: 2035-42. PMID 20535557 DOI: 10.1007/s11064-010-0206-3  0.88
2010 Patel SD, Le-Niculescu H, Koller DL, Green SD, Lahiri DK, McMahon FJ, Nurnberger JI, Niculescu AB. Coming to grips with complex disorders: genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 850-77. PMID 20468069 DOI: 10.1002/ajmg.b.31087  0.88
2010 Lahiri DK, Maloney B. Beyond the signaling effect role of amyloid-ß42 on the processing of APP, and its clinical implications. Experimental Neurology. 225: 51-4. PMID 20451519 DOI: 10.1016/j.expneurol.2010.04.018  0.88
2010 Li Y, Duffy KB, Ottinger MA, Ray B, Bailey JA, Holloway HW, Tweedie D, Perry T, Mattson MP, Kapogiannis D, Sambamurti K, Lahiri DK, Greig NH. GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 19: 1205-19. PMID 20308787 DOI: 10.3233/JAD-2010-1314  0.88
2010 Lahiri DK. Editorial--"Current aging science": an important platform for reporting advances in aging-related research. Current Aging Science. 3: 1-2. PMID 20298164 DOI: 10.2174/1874609811003010001  0.88
2010 Lahiri DK, Maloney B. The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps. Experimental Gerontology. 45: 291-6. PMID 20064601 DOI: 10.1016/j.exger.2010.01.001  0.88
2010 Ray B, Banerjee PK, Greig NH, Lahiri DK. Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (A beta) peptide in the human neuroblastoma cells. Neuroscience Letters. 470: 1-5. PMID 19948208 DOI: 10.1016/j.neulet.2009.11.016  0.88
2010 Bailey JA, Lahiri DK. A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease. Journal of Neurochemistry. 112: 843-53. PMID 19912467 DOI: 10.1111/j.1471-4159.2009.06490.x  0.88
2010 Alley GM, Bailey JA, Chen D, Ray B, Puli LK, Tanila H, Banerjee PK, Lahiri DK. Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice. Journal of Neuroscience Research. 88: 143-54. PMID 19642202 DOI: 10.1002/jnr.22172  0.88
2010 Maloney B, Ge YW, Petersen RC, Hardy J, Rogers JT, Pérez-Tur J, Lahiri DK. Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 185-201. PMID 19504470 DOI: 10.1002/ajmg.b.30973  0.88
2010 Konietzko U, Goodger ZV, Meyer M, Kohli BM, Bosset J, Lahiri DK, Nitsch RM. Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories. Neurobiology of Aging. 31: 58-73. PMID 18403052 DOI: 10.1016/j.neurobiolaging.2008.03.001  0.88
2010 Lahiri DK, Maloney B. Genomics of Brain Aging: Apolipoprotein E Encyclopedia of Neuroscience. 685-693. DOI: 10.1016/B978-008045046-9.00136-4  0.88
2009 Lahiri DK. Progress and vision for 'Current Aging Science'. Current Aging Science. 2: 1-2. PMID 20021394  0.88
2009 Lahiri DK. A SMART plan for new investigators. Science (New York, N.Y.). 326: 935-6. PMID 19965496 DOI: 10.1126/science.326.5955.935-c  0.88
2009 Lahiri DK, Maloney B, Zawia NH. The LEARn model: An epigenetic explanation for idiopathic neurobiological diseases Molecular Psychiatry. 14: 992-1003. PMID 19851280 DOI: 10.1038/mp.2009.82  0.88
2009 Ray B, Bailey JA, Sarkar S, Lahiri DK. Molecular and immunocytochemical characterization of primary neuronal cultures from adult rat brain: Differential expression of neuronal and glial protein markers. Journal of Neuroscience Methods. 184: 294-302. PMID 19720084 DOI: 10.1016/j.jneumeth.2009.08.018  0.88
2009 Lahiri DK. Perspective on mild cognitive impairment (MCI). Current Alzheimer Research. 6: 322. PMID 19689228 DOI: 10.2174/156720509788929246  0.88
2009 Maloney B, Ray B, Hayden EP, Nurnberger JI, Lahiri DK. Development and validation of the high-quality 'rapid method for swab' to genotype the HTTLPR serotonin transporter (SLC6A4) promoter polymorphism. Psychiatric Genetics. 19: 72-82. PMID 19668112 DOI: 10.1097/YPG.0b013e3283208091  0.88
2009 Ray B, Simon JR, Lahiri DK. Determination of high-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity in the same population of cultured cells. Brain Research. 1297: 160-8. PMID 19660442 DOI: 10.1016/j.brainres.2009.07.096  0.88
2009 Ray B, Lahiri DK. Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin. Current Opinion in Pharmacology. 9: 434-44. PMID 19656726 DOI: 10.1016/j.coph.2009.06.012  0.88
2009 Dosunmu R, Wu J, Adwan L, Maloney B, Basha MR, McPherson CA, Harry GJ, Rice DC, Zawia NH, Lahiri DK. Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice. Journal of Alzheimer's Disease : Jad. 18: 211-30. PMID 19584442 DOI: 10.3233/JAD-2009-1138  0.88
2009 Martínez A, Lahiri DK, Giacobini E, Greig NH. Advances in Alzheimer therapy: understanding pharmacological approaches to the disease. Current Alzheimer Research. 6: 83-5. PMID 19355842 DOI: 10.2174/156720509787602924  0.88
2009 Zawia NH, Lahiri DK, Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radical Biology & Medicine. 46: 1241-9. PMID 19245828 DOI: 10.1016/j.freeradbiomed.2009.02.006  0.88
2009 Schneider LS, Lahiri DK. The perils of Alzheimer's drug development. Current Alzheimer Research. 6: 77-8. PMID 19199878 DOI: 10.2174/156720509787313871  0.88
2009 Lahiri DK. Celebrating the fifth year anniversary of current Alzheimer research. Current Alzheimer Research. 6: 1-3. PMID 19199869 DOI: 10.2174/156720509787313989  0.88
2009 Cahill CM, Lahiri DK, Huang X, Rogers JT. Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochimica Et Biophysica Acta. 1790: 615-28. PMID 19166904 DOI: 10.1016/j.bbagen.2008.12.001  0.88
2009 Li Y, Perry T, Kindy MS, Harvey BK, Tweedie D, Holloway HW, Powers K, Shen H, Egan JM, Sambamurti K, Brossi A, Lahiri DK, Mattson MP, Hoffer BJ, Wang Y, et al. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. 106: 1285-90. PMID 19164583 DOI: 10.1073/pnas.0806720106  0.88
2009 Lahiri DK. Editorial - progress and vision for 'current aging science' Current Aging Science. 2: 1-2. DOI: 10.2174/1874609810902010001  0.88
2009 Lahiri DK, Maloney B, Zawia NH. How biochemical pathways for disease may be triggered by early-life events Current Hypotheses and Research Milestones in Alzheimer's Disease. 205-214. DOI: 10.1007/978-0-387-87995-6_17  0.88
2008 Lahiri DK. A new journal with an integrated approach in the study of aging and longevity. Current Aging Science. 1: 1-3. PMID 20021366  0.88
2008 Rogers JT, Bush AI, Cho HH, Smith DH, Thomson AM, Friedlich AL, Lahiri DK, Leedman PJ, Huang X, Cahill CM. Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease. Biochemical Society Transactions. 36: 1282-7. PMID 19021541 DOI: 10.1042/BST0361282  0.88
2008 Thakur MK, Wadhwa R, Lahiri DK. Editorial: special issue of Biogerontology on brain aging. Biogerontology. 9: 367-8. PMID 18836857 DOI: 10.1007/s10522-008-9180-4  0.88
2008 Lahiri DK, Zawia NH, Greig NH, Sambamurti K, Maloney B. Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" model. Biogerontology. 9: 375-9. PMID 18668339 DOI: 10.1007/s10522-008-9162-6  0.88
2008 Wen Y, Yu WH, Maloney B, Bailey J, Ma J, Marié I, Maurin T, Wang L, Figueroa H, Herman M, Krishnamurthy P, Liu L, Planel E, Lau LF, Lahiri DK, et al. Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron. 57: 680-90. PMID 18341989 DOI: 10.1016/j.neuron.2008.02.024  0.88
2008 Brock B, Basha R, DiPalma K, Anderson A, Harry GJ, Rice DC, Maloney B, Lahiri DK, Zawia NH. Co-localization and distribution of cerebral APP and SP1 and its relationship to amyloidogenesis. Journal of Alzheimer's Disease : Jad. 13: 71-80. PMID 18334759  0.88
2008 Lahiri DK. 'Current Alzheimer Research': update on lipids, estrogen, neurotrophins and their roles in neurodegeneration. Current Alzheimer Research. 5: 1-3. PMID 18288925 DOI: 10.2174/156720508783884639  0.88
2008 Wu J, Basha MR, Brock B, Cox DP, Cardozo-Pelaez F, McPherson CA, Harry J, Rice DC, Maloney B, Chen D, Lahiri DK, Zawia NH. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 3-9. PMID 18171917 DOI: 10.1523/JNEUROSCI.4405-07.2008  0.88
2008 Hayden EP, Dougherty LR, Maloney B, Olino TM, Sheikh H, Durbin CE, Nurnberger JI, Lahiri DK, Klein DN. Early-emerging cognitive vulnerability to depression and the serotonin transporter promoter region polymorphism. Journal of Affective Disorders. 107: 227-30. PMID 17804080 DOI: 10.1016/j.jad.2007.07.028  0.88
2008 Lahiri DK. Progress of 'Current Alzheimer Research' and update on roles of lipids, estrogen, neurotrophins and cytokines in Alzheimer's disease Current Alzheimer Research. 5: 1-3. DOI: 10.2174/156720508783884639  0.88
2007 Bandyopadhyay S, Goldstein LE, Lahiri DK, Rogers JT. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease. Current Medicinal Chemistry. 14: 2848-64. PMID 18045131 DOI: 10.2174/092986707782360060  0.88
2007 Greig NH, Giacobini E, Lahiri DK. Advances in Alzheimer therapy: development of innovative new strategies. Current Alzheimer Research. 4: 336-9. PMID 17908034 DOI: 10.2174/156720507781788819  0.88
2007 Maloney B, Ge YW, Alley GM, Lahiri DK. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease. Journal of Neurochemistry. 103: 1237-57. PMID 17854398 DOI: 10.1111/j.1471-4159.2007.04831.x  0.88
2007 Rice SG, Nowak L, Duysen EG, Lockridge O, Lahiri DK, Reyes PF. Neuropathological and immunochemical studies of brain parenchyma in acetylcholinesterase knockout mice: implications in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 11: 481-9. PMID 17656828  0.88
2007 Lahiri DK, Alley GM, Tweedie D, Chen D, Greig NH. Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease. Neuromolecular Medicine. 9: 157-68. PMID 17627035 DOI: 10.1007/s12017-007-0005-4  0.88
2007 Lahiri DK, Maloney B, Basha MR, Ge YW, Zawia NH. How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD. Current Alzheimer Research. 4: 219-28. PMID 17430250 DOI: 10.2174/156720507780362164  0.88
2007 Hayden EP, Dougherty LR, Maloney B, Emily Durbin C, Olino TM, Nurnberger JI, Lahiri DK, Klein DN. Temperamental fearfulness in childhood and the serotonin transporter promoter region polymorphism: a multimethod association study. Psychiatric Genetics. 17: 135-42. PMID 17417056 DOI: 10.1097/YPG.0b013e3280147847  0.88
2007 Tweedie D, Milman A, Holloway HW, Li Y, Harvey BK, Shen H, Pistell PJ, Lahiri DK, Hoffer BJ, Wang Y, Pick CG, Greig NH. Apoptotic and behavioral sequelae of mild brain trauma in mice. Journal of Neuroscience Research. 85: 805-15. PMID 17243171 DOI: 10.1002/jnr.21160  0.88
2007 Veronesi MC, Yard M, Jackson J, Lahiri DK, Kubek MJ. An analog of thyrotropin-releasing hormone (TRH) is neuroprotective against glutamate-induced toxicity in fetal rat hippocampal neurons in vitro. Brain Research. 1128: 79-85. PMID 17125753 DOI: 10.1016/j.brainres.2006.10.047  0.88
2007 Sharman EH, Bondy SC, Sharman KG, Lahiri D, Cotman CW, Perreau VM. Effects of melatonin and age on gene expression in mouse CNS using microarray analysis. Neurochemistry International. 50: 336-44. PMID 17118492 DOI: 10.1016/j.neuint.2006.09.001  0.88
2007 Lahiri DK, Chen D, Maloney B, Holloway HW, Yu QS, Utsuki T, Giordano T, Sambamurti K, Greig NH. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice. The Journal of Pharmacology and Experimental Therapeutics. 320: 386-96. PMID 17003227 DOI: 10.1124/jpet.106.112102  0.4
2007 Lahiri DK. Alzheimer's disease: Highlights from research on hormones, growth factors and signaling pathways Current Alzheimer Research. 4: 1-2. DOI: 10.2174/156720507779939797  0.88
2006 Bailey JA, Lahiri DK. Neuronal differentiation is accompanied by increased levels of SNAP-25 protein in fetal rat primary cortical neurons: implications in neuronal plasticity and Alzheimer's disease. Annals of the New York Academy of Sciences. 1086: 54-65. PMID 17185505 DOI: 10.1196/annals.1377.001  0.88
2006 Lahiri DK. Where the actions of environment (nutrition), gene and protein meet: beneficial role of fruit and vegetable juices in potentially delaying the onset of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 10: 359-61; discussion 3. PMID 17183145  0.88
2006 Lahiri DK, Ge YW, Rogers JT, Sambamurti K, Greig NH, Maloney B. Taking down the unindicted co-conspirators of amyloid beta-peptide-mediated neuronal death: shared gene regulation of BACE1 and APP genes interacting with CREB, Fe65 and YY1 transcription factors. Current Alzheimer Research. 3: 475-83. PMID 17168646 DOI: 10.2174/156720506779025224  0.88
2006 Sokol DK, Chen D, Farlow MR, Dunn DW, Maloney B, Zimmer JA, Lahiri DK. High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. Journal of Child Neurology. 21: 444-9. PMID 16948926 DOI: 10.2310/7010.2006.00130  0.88
2006 Maloney B, Ge YW, Greig NH, Lahiri DK. Characterization of the human β-secretase 2 (BACE2) 5′-flanking region: Identification of a 268-bp region as the basal BACE2 promoter Journal of Molecular Neuroscience. 29: 81-99. PMID 16757812 DOI: 10.1385/JMN:29:1:81  0.88
2006 Lahiri DK, Maloney B, Ge YW. Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells Journal of Molecular Neuroscience. 29: 65-80. PMID 16757811 DOI: 10.1385/JMN:29:1:65  0.88
2006 Lahiri DK, Maloney B, Ge YW. BACE1 gene promoter is differentially regulated: Detection of a novel promoter region for its cell type-specific regulation Journal of Molecular Neuroscience. 28: 193-210. PMID 16679558 DOI: 10.1385/JMN:28:2:193  0.88
2006 Luo W, Yu QS, Kulkarni SS, Parrish DA, Holloway HW, Tweedie D, Shafferman A, Lahiri DK, Brossi A, Greig NH. Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine. Journal of Medicinal Chemistry. 49: 2174-85. PMID 16570913 DOI: 10.1021/jm050578p  0.88
2006 Bolin CM, Basha R, Cox D, Zawia NH, Maloney B, Lahiri DK, Cardozo-Pelaez F. Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 788-90. PMID 16484331 DOI: 10.1096/fj.05-5091fje  0.88
2006 Lahiri DK. Discourse among referees and editors would help [8] Nature. 439: 784. PMID 16482130 DOI: 10.1038/439784d  0.88
2006 Sambamurti K, Suram A, Venugopal C, Prakasam A, Zhou Y, Lahiri DK, Greig NH. A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis. Current Alzheimer Research. 3: 81-90. PMID 16472208 DOI: 10.2174/156720506775697142  0.88
2006 Kernek KL, Trofatter JA, Mayeda AR, Lahiri DK, Hofstetter JR. A single copy of carbonic anhydrase 2 restores wild-type circadian period to carbonic anhydrase II-deficient mice. Behavior Genetics. 36: 301-8. PMID 16408247 DOI: 10.1007/s10519-005-9032-9  0.88
2006 Lahiri DK, LaFerla FM. Marking the centennial of Alzheimer's first report of the disease with a perspective of ongoing research and future challenge Current Alzheimer Research. 3: 409-410. DOI: 10.2174/156720506779025260  0.88
2006 Lahiri DK. Editorial- Update on Current Alzheimer Research Current Alzheimer Research. 3: 93-94. DOI: 10.2174/156720506776383040  0.88
2006 Lahiri DK. Editorial - A milestone for current Alzheimer research Current Alzheimer Research. 3: 1. DOI: 10.2174/156720506775697115  0.88
2006 Sobue G, Takahashi M, Yoshida J, Kaibuchi K, Naoe T, Lahiri DK. Integrated molecular medicine for neuronal and neoplastic disorders Annals of the New York Academy of Sciences. 1086: xi-xii. DOI: 10.1196/annals.1377.015  0.88
2006 Lahiri DK, Maloney B. Genes are not our destiny: The somatic epitype bridges between the genotype and the phenotype Nature Reviews Neuroscience. 7. DOI: 10.1038/nrn2022-c1  0.88
2005 Lahiri DK, Chen DM, Lahiri P, Bondy S, Greig NH. Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases. Annals of the New York Academy of Sciences. 1056: 430-49. PMID 16387707 DOI: 10.1196/annals.1352.008  0.88
2005 Zhang Z, Abrahams MR, Hunt LA, Suttles J, Marshall W, Lahiri DK, Kotwal GJ. The vaccinia virus N1L protein influences cytokine secretion in vitro after infection. Annals of the New York Academy of Sciences. 1056: 69-86. PMID 16387678 DOI: 10.1196/annals.1352.005  0.88
2005 Lahiri DK. Editorial - Advances of Alzheimer's disease research: Crossroad of basic and translational studies Current Alzheimer Research. 2: 495-496. PMID 16375652 DOI: 10.2174/156720505774932250  0.88
2005 Greig NH, Utsuki T, Ingram DK, Wang Y, Pepeu G, Scali C, Yu QS, Mamczarz J, Holloway HW, Giordano T, Chen D, Furukawa K, Sambamurti K, Brossi A, Lahiri DK. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Proceedings of the National Academy of Sciences of the United States of America. 102: 17213-8. PMID 16275899 DOI: 10.1073/pnas.0508575102  0.88
2005 Lahiri DK, Ge YW, Maloney B, Wavrant-De Vrièze F, Hardy J. Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease Neurobiology of Aging. 26: 1329-1341. PMID 16243604 DOI: 10.1016/j.neurobiolaging.2004.11.005  0.88
2005 Basha MR, Murali M, Siddiqi HK, Ghosal K, Siddiqi OK, Lashuel HA, Ge YW, Lahiri DK, Zawia NH. Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 2083-4. PMID 16230335 DOI: 10.1096/fj.05-4375fje  0.88
2005 Nie Y, Schoepp DD, Klaunig JE, Yard M, Lahiri DK, Kubek MJ. Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro. Brain Research. 1054: 45-54. PMID 16055093 DOI: 10.1016/j.brainres.2005.06.077  0.88
2005 Greig NH, Lahiri DK, Giacobini E. Editorial: advances in Alzheimer therapy: something old, something new, something borrowed, something blue. Current Alzheimer Research. 2: 275-9. PMID 15974892 DOI: 10.2174/1567205054367865  0.88
2005 Du Y, Chen X, Wei X, Bales KR, Berg DT, Paul SM, Farlow MR, Maloney B, Ge YW, Lahiri DK. NF-(kappa)B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells. Brain Research. Molecular Brain Research. 136: 177-88. PMID 15893602 DOI: 10.1016/j.molbrainres.2005.02.001  0.88
2005 Lahiri DK, Ge YW, Maloney B. Characterization of the APP proximal promoter and 5′-untranslated regions: Identification or cell type-specific domains and implications in APP gene expression and Alzheimer's disease Faseb Journal. 19: 653-655. PMID 15703276 DOI: 10.1096/fj.04-2900fje  0.88
2005 Basha MR, Wei W, Bakheet SA, Benitez N, Siddiqi HK, Ge YW, Lahiri DK, Zawia NH. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 823-9. PMID 15673661 DOI: 10.1523/JNEUROSCI.4335-04.2005  0.88
2005 Lahiri DK. Editorial - The A's and M's of Alzheimer's disease Current Alzheimer Research. 2: 387. DOI: 10.2174/156720505774330546  0.88
2005 Lahiri DK. Editorial - Progress of Current Alzheimer Research Current Alzheimer Research. 2: 1-2. DOI: 10.2174/1567205052772696  0.88
2005 Kotwal GJ, Lahiri DK. Natural products and molecular therapy: Preface Annals of the New York Academy of Sciences. 1056. DOI: 10.1196/annals.1352.41  0.88
2004 Lahiri DK. Advances in the four major pillars of Alzheimer's disease research: pathobiology, genetics, diagnosis, and treatment Curr Alzheimer Res. 1. PMID 15975062 DOI: 10.2174/1567205043480537  0.88
2004 Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, Rogers JT, Ovadia H, Lahiri DK. New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists. Annals of the New York Academy of Sciences. 1035: 290-315. PMID 15681814 DOI: 10.1196/annals.1332.018  0.88
2004 Lahiri DK, Chen D, Lahiri P, Rogers JT, Greig NH, Bondy S. Melatonin, metals, and gene expression: implications in aging and neurodegenerative disorders. Annals of the New York Academy of Sciences. 1035: 216-30. PMID 15681810 DOI: 10.1196/annals.1332.014  0.88
2004 Reynolds DN, Smith SA, Zhang YP, Mengsheng Q, Lahiri DK, Morassutti DJ, Shields CB, Kotwal GJ. Vaccinia virus complement control protein reduces inflammation and improves spinal cord integrity following spinal cord injury. Annals of the New York Academy of Sciences. 1035: 165-78. PMID 15681807 DOI: 10.1196/annals.1332.011  0.88
2004 Kulkarni AP, Kellaway LA, Lahiri DK, Kotwal GJ. Neuroprotection from complement-mediated inflammatory damage. Annals of the New York Academy of Sciences. 1035: 147-64. PMID 15681806 DOI: 10.1196/annals.1332.010  0.88
2004 Venti A, Giordano T, Eder P, Bush AI, Lahiri DK, Greig NH, Rogers JT. The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region. Annals of the New York Academy of Sciences. 1035: 34-48. PMID 15681799 DOI: 10.1196/annals.1332.003  0.88
2004 Lahiri DK, Ge YW. Role of the APP promoter in Alzheimer's disease: Cell type-specific expression of the β-amyloid precursor protein Annals of the New York Academy of Sciences. 1030: 310-316. PMID 15659812 DOI: 10.1196/annals.1329.039  0.88
2004 Billings B, Smith SA, Zhang Z, Lahiri DK, Kotwal GJ. Lack of N1L gene expression results in a significant decrease of vaccinia virus replication in mouse brain. Annals of the New York Academy of Sciences. 1030: 297-302. PMID 15659810 DOI: 10.1196/annals.1329.037  0.88
2004 Lahiri DK. Functional characterization of amyloid β precursor protein regulatory elements: Rationale for the identification of genetic polymorphism Annals of the New York Academy of Sciences. 1030: 282-288. PMID 15659808 DOI: 10.1196/annals.1329.035  0.88
2004 Lahiri DK, Rogers JT, Greig NH, Sambamurti K. Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents. Current Pharmaceutical Design. 10: 3111-9. PMID 15544501 DOI: 10.2174/1381612043383331  0.88
2004 Ge YW, Ghosh C, Song W, Maloney B, Lahiri DK. Mechanism of promoter activity of the beta-amyloid precursor protein gene in different cell lines: identification of a specific 30 bp fragment in the proximal promoter region. Journal of Neurochemistry. 90: 1432-44. PMID 15341527 DOI: 10.1111/j.1471-4159.2004.02608.x  0.88
2004 Rogers JT, Lahiri DK. Metal and inflammatory targets for Alzheimer's disease. Current Drug Targets. 5: 535-51. PMID 15270200 DOI: 10.2174/1389450043345272  0.88
2004 Sambamurti K, Granholm AC, Kindy MS, Bhat NR, Greig NH, Lahiri DK, Mintzer JE. Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors. Current Drug Targets. 5: 517-28. PMID 15270198 DOI: 10.2174/1389450043345335  0.88
2004 Maloney B, Ge YW, Greig N, Lahiri DK. Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: Implications in Alzheimer's disease Faseb Journal. 18: 1288-1290. PMID 15208260 DOI: 10.1096/fj.03-1703fje  0.88
2004 Lahiri DK. Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene Journal of Molecular Neuroscience : Mn. 23: 225-233. PMID 15181251  0.88
2004 Lahiri DK, Sambamurti K, Bennett DA. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiology of Aging. 25: 651-60. PMID 15172744 DOI: 10.1016/j.neurobiolaging.2003.12.024  0.88
2004 Lahiri DK, Greig NH. Lethal weapon: Amyloid β-peptide, role in the oxidative stress and neurodegeneration of Alzheimer's disease Neurobiology of Aging. 25: 581-587. PMID 15172733 DOI: 10.1016/j.neurobiolaging.2004.02.002  0.88
2004 Evans RM, Hui S, Perkins A, Lahiri DK, Poirier J, Farlow MR. Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology. 62: 1869-71. PMID 15159498 DOI: 10.1212/01.WNL.0000125323.15458.3F  0.88
2004 Lahiri DK, Chen D, Ge YW, Bondy SC, Sharman EH. Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. Journal of Pineal Research. 36: 224-31. PMID 15066046 DOI: 10.1111/j.1600-079X.2004.00121.x  0.88
2004 Lahiri DK, Ge YW, Sharman EH, Bondy SC. Age-related changes in serum melatonin in mice: higher levels of combined melatonin and 6-hydroxymelatonin sulfate in the cerebral cortex than serum, heart, liver and kidney tissues. Journal of Pineal Research. 36: 217-23. PMID 15066045 DOI: 10.1111/j.1600-079X.2004.00120.x  0.88
2004 Ge YW, Maloney B, Sambamurti K, Lahiri DK. Functional characterization of the 5' flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1037-9. PMID 15059977 DOI: 10.1096/fj.03-1379fje  0.88
2004 Sambamurti K, Kinsey R, Maloney B, Ge YW, Lahiri DK. Gene structure and organization of the human beta-secretase (BACE) promoter. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1034-6. PMID 15059975 DOI: 10.1096/fj.03-1378fje  0.88
2004 Sharman EH, Sharman KG, Ge YW, Lahiri DK, Bondy SC. Age-related changes in murine CNS mRNA gene expression are modulated by dietary melatonin. Journal of Pineal Research. 36: 165-70. PMID 15009506  0.88
2004 Bellingham SA, Lahiri DK, Maloney B, La Fontaine S, Multhaup G, Camakaris J. Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene. The Journal of Biological Chemistry. 279: 20378-86. PMID 14985339 DOI: 10.1074/jbc.M400805200  0.4
2004 Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC. Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. Journal of Neuroscience Research. 75: 565-72. PMID 14743440 DOI: 10.1002/jnr.10877  0.88
2004 Lahiri DK. Alzheimer's disease - Current trends in basic and clinical research. Highlights from the 16th ECNP Expert Opinion On Investigational Drugs. 13: 79-86. PMID 14680456 DOI: 10.1517/eoid.  0.88
2004 Lahiri DK. Preface: Current research trend on neurodegeneration, neuroinflammation, and neuroprotection Annals of the New York Academy of Sciences. 1035. DOI: 10.1196/annals.1332.022  0.88
2004 Lahiri DK. Preface: Highlights of recent progress in Alzheimer's disease research Current Drug Targets. 5.  0.88
2003 Kanthasamy AG, Kitazawa M, Kaul S, Yang Y, Lahiri DK, Anantharam V, Kanthasamy A. Proteolytic activation of proapoptotic kinase PKCdelta is regulated by overexpression of Bcl-2: implications for oxidative stress and environmental factors in Parkinson's disease. Annals of the New York Academy of Sciences. 1010: 683-6. PMID 15033812 DOI: 10.1196/annals.1299.125  0.88
2003 Lahiri DK, Ghosh C, Ge YW. A Proximal Gene Promoter Region for the β-Amyloid Precursor Protein Provides a Link between Development, Apoptosis, and Alzheimer's Disease Annals of the New York Academy of Sciences. 1010: 643-647. PMID 15033805 DOI: 10.1196/annals.1299.118  0.88
2003 Zhu X, Giordano T, Yu QS, Holloway HW, Perry TA, Lahiri DK, Brossi A, Greig NH. Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity. Journal of Medicinal Chemistry. 46: 5222-9. PMID 14613324 DOI: 10.1021/jm030152f  0.88
2003 Lahiri DK. 6th International Conference on Alzheimer's Disease and Parkinson's Disease Expert Opinion On Investigational Drugs. 12: 1433-1440. PMID 12882629 DOI: 10.1517/eoid.12.8.1433.21775  0.88
2003 Marlow L, Canet RM, Haugabook SJ, Hardy JA, Lahiri DK, Sambamurti K. APH1, PEN2, and Nicastrin increase Abeta levels and gamma-secretase activity. Biochemical and Biophysical Research Communications. 305: 502-9. PMID 12763021 DOI: 10.1016/S0006-291X(03)00797-6  0.88
2003 Lahiri DK, Chen D, Vivien D, Ge YW, Greig NH, Rogers JT. Role of cytokines in the gene expression of amyloid beta-protein precursor: identification of a 5'-UTR-binding nuclear factor and its implications in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 5: 81-90. PMID 12719626  0.88
2003 Lesné S, Docagne F, Gabriel C, Liot G, Lahiri DK, Buée L, Plawinski L, Delacourte A, MacKenzie ET, Buisson A, Vivien D. Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. The Journal of Biological Chemistry. 278: 18408-18. PMID 12626500 DOI: 10.1074/jbc.M300819200  0.88
2003 Lahiri DK, Farlow MR, Sambamurti K, Greig NH, Giacobini E, Schneider LS. A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Current Drug Targets. 4: 97-112. PMID 12558063 DOI: 10.2174/1389450033346957  0.88
2003 Lahiri DK, Farlow MR. Review: Cholinesterase inhibitors have a modest effect on neuropsychiatric and functional outcomes in Alzheimer's disease: Commentary Evidence-Based Mental Health. 6: 94. DOI: 10.1136/ebmh.6.3.94  0.88
2002 Greig NH, Lahiri DK, Sambamurti K. Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. International Psychogeriatrics / Ipa. 14: 77-91. PMID 12636181 DOI: 10.1017/S1041610203008676  0.88
2002 Ge YW, Lahiri DK. Regulation of promoter activity of the APP gene by cytokines and growth factors: Implications in Alzheimer's disease Annals of the New York Academy of Sciences. 973: 463-467. PMID 12485912  0.88
2002 Lahiri DK, Alley GM, Ge YW, Du Y. Functional characterization of the 5′-regulatory region of the murine apolipoprotein gene Annals of the New York Academy of Sciences. 973: 340-344. PMID 12485890  0.88
2002 Lahiri DK, Kotwal GJ, Farlow MR, Sima A, Kupsky W, Sarkar FH, Sambamurti K. The role of the carboxyl-terminal fragments of amyloid precursor protein in Alzheimer's disease. Annals of the New York Academy of Sciences. 973: 334-9. PMID 12485889  0.88
2002 Kotwal GJ, Lahiri DK, Hicks R. Potential intervention by vaccinia virus complement control protein of the signals contributing to the progression of central nervous system injury to Alzheimer's disease Annals of the New York Academy of Sciences. 973: 317-322. PMID 12485887  0.88
2002 Rogers JT, Randall JD, Eder PS, Huang X, Bush AI, Tanzi RE, Venti A, Payton SM, Giordano T, Nagano S, Cahill CM, Moir R, Lahiri DK, Greig N, Sarang SS, et al. Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated region. Journal of Molecular Neuroscience : Mn. 19: 77-82. PMID 12212798 DOI: 10.1007/s12031-002-0014-6  0.88
2002 Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, et al. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. The Journal of Biological Chemistry. 277: 45518-28. PMID 12198135 DOI: 10.1074/jbc.M207435200  0.88
2002 Lahiri DK, Utsuki T, Chen D, Farlow MR, Shoaib M, Ingram DK, Greig NH. Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins. Annals of the New York Academy of Sciences. 965: 364-72. PMID 12105112 DOI: 10.1111/j.1749-6632.2002.tb04178.x  0.88
2002 Sambamurti K, Greig NH, Lahiri DK. Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease. Neuromolecular Medicine. 1: 1-31. PMID 12025813 DOI: 10.1385/NMM:1:1:1  0.88
2002 Bondy SC, Yang YE, Walsh TJ, Gie YW, Lahiri DK. Dietary modulation of age-related changes in cerebral pro-oxidant status Neurochemistry International. 40: 123-130. PMID 11738478 DOI: 10.1016/S0197-0186(01)00084-5  0.88
2002 Lahiri DK, Farlow MR, Greig NH, Sambamurti K. Current drug targets for Alzheimer's disease treatment Drug Development Research. 56: 267-281. DOI: 10.1002/ddr.10081  0.88
2002 Sambamurti K, Hardy J, Refolo LM, Lahiri DK. Targeting APP metabolism for the treatment of Alzheimer's disease Drug Development Research. 56: 211-227. DOI: 10.1002/ddr.10077  0.88
2000 Lahiri DK, Farlow MR, Hintz N, Utsuki T, Greig NH. Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease. Acta Neurologica Scandinavica. Supplementum. 176: 60-7. PMID 11273593 DOI: 10.1034/j.1600-0404.2000.00309.x  0.88
2000 Greig NH, De Micheli E, Holloway HW, Yu QS, Utsuki T, Perry TA, Brossi A, Ingram DK, Deutsch J, Lahiri DK, Soncrant TT. The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics. Acta Neurologica Scandinavica. Supplementum. 176: 74-84. PMID 11261809 DOI: 10.1034/j.1600-0404.2000.00311.x  0.88
2000 Ghosh C, Song W, Lahiri DK. Efficient DNA transfection in neuronal and astrocytic cell lines Molecular Biology Reports. 27: 113-121. PMID 11092558 DOI: 10.1023/A:1007173906990  0.88
2000 Lahiri DK, Ge YW. Electrophoretic mobility shift assay for the detection of specific DNA-protein complex in nuclear extracts from the cultured cells and frozen autopsy human brain tissue Brain Research Protocols. 5: 257-265. PMID 10906491 DOI: 10.1016/S1385-299X(00)00021-0  0.88
2000 Nurnberger JI, Adkins S, Lahiri DK, Mayeda A, Hu K, Lewy A, Miller A, Bowman ES, Miller MJ, Rau LN, Smiley C, Davis-Singh D. Melatonin suppression by light in euthymic bipolar and unipolar patients Archives of General Psychiatry. 57: 572-579. PMID 10839335 DOI: 10.1001/archpsyc.57.6.572  0.88
2000 Lahiri DK, Song W, Ge YW. Analysis of the 5'-flanking region of the β-amyloid precursor protein gene that contributes to increased promoter activity in differentiated neuronal cells Molecular Brain Research. 77: 185-198. PMID 10837914 DOI: 10.1016/S0169-328X(00)00051-6  0.88
2000 Lahiri DK, Ge YW, Farlow MR. Effect of a memory-enhancing drug, AIT-082, on the level of synaptophysin. Annals of the New York Academy of Sciences. 903: 387-93. PMID 10818529  0.88
2000 Lahiri DK, Zhang A, Hu K, Nurnberger JI. Human G(olf) protein in cell lines derived from control and bipolar subjects American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 565.  0.88
1999 Lahiri DK, Davis D, Nurnberger JI. Detection of specific protein bands with melatonin-like immunoreactivity in different cell lines and human brain regions Iubmb Life. 48: 127-132. PMID 10791927 DOI: 10.1080/152165499307530  0.88
1999 Ghosh C, Lahiri DK. Increased vulnerability of neuronal cell lines to sodium nitroprusside- mediated toxicity is caused by the decreased level of nitric oxide metabolites Journal of Molecular Neuroscience. 13: 77-92. PMID 10691295  0.88
1999 Lahiri DK, Ghosh C. Interactions between melatonin, reactive oxygen species, and nitric oxide Annals of the New York Academy of Sciences. 893: 325-330. PMID 10672259  0.88
1999 Farlow MR, Cyrus PA, Nadel A, Lahiri DK, Brashear A, Gulanski B. Metrifonate treatment of AD: influence of APOE genotype. Neurology. 53: 2010-6. PMID 10599773 DOI: 10.1212/WNL.53.9.2010  0.88
1999 Daly J, Lahiri DK, Kotwal GJ. Examination of the interactions of the amyloid precursor protein carboxyl terminus to intracellular protein: Possible role in apoptosis Progress in Neuro-Psychopharmacology and Biological Psychiatry. 23: 861-875. PMID 10509380 DOI: 10.1016/S0278-5846(99)00046-9  0.88
1999 Lahiri DK, Nall C, Ge YW. Promoter activity of the beta-amyloid precursor protein gene is negatively modulated by an upstream regulatory element Molecular Brain Research. 71: 32-41. PMID 10407184 DOI: 10.1016/S0169-328X(99)00150-3  0.88
1999 Lahiri DK. Melatonin affects the metabolism of the β-amyloid precursor protein in different cell types Journal of Pineal Research. 26: 137-146. PMID 10231726  0.88
1998 Song W, Lahiri DK. Isolation of the genomic clone of the rhesus monkey beta-amyloid precursor protein Biochemistry and Molecular Biology International. 46: 755-764. PMID 9844737  0.88
1998 Song W, Lahiri DK. Molecular cloning of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein: Structural characterization and a comparative study with other species Gene. 217: 151-164. PMID 9841227 DOI: 10.1016/S0378-1119(98)00337-0  0.88
1998 Daly J, Lahiri DK, Justus DE, Kotwal GJ. Detection of the membrane-retained carboxy-terminal tail containing polypeptides of the amyloid precursor protein in tissue from Alzheimer's disease brain. Life Sciences. 63: 2121-31. PMID 9839536  0.88
1998 Lahiri DK, Farlow MR, Sambamurti K. The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells. Brain Research. Molecular Brain Research. 62: 131-40. PMID 9813282 DOI: 10.1016/S0169-328X(98)00236-8  0.88
1998 Song W, Lahiri DK. Functional identification of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein Gene. 217: 165-176. PMID 9795200 DOI: 10.1016/S0378-1119(98)00340-0  0.88
1998 Sambamurti K, Lahiri DK. ERAB contains a putative noncleavable signal peptide Biochemical and Biophysical Research Communications. 249: 546-549. PMID 9712734 DOI: 10.1006/bbrc.1998.9178  0.88
1998 Lahiri DK. An region upstream of the gene promoter for the β-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells Molecular Brain Research. 58: 112-122. PMID 9685602 DOI: 10.1016/S0169-328X(98)00115-6  0.88
1998 Farlow MR, Lahiri DK, Poirier J, Davignon J, Schneider L, Hui SL. Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease. Neurology. 50: 669-77. PMID 9521254  0.88
1998 Lahiri DK, Zhang A, Nurnberger JI. Effect of lithium treatment on the Gα-OLF protein in transformed lymphoblastoid cell lines derived from unaffected and bipolar affective disorder subjects American Journal of Medical Genetics - Neuropsychiatric Genetics. 81: 478.  0.88
1997 Hofstetter JR, Zhang A, Mayeda AR, Guscar T, Nurnberger JI, Lahiri DK. Genomic DNA from mice: a comparison of recovery methods and tissue sources. Biochemical and Molecular Medicine. 62: 197-202. PMID 9441873 DOI: 10.1006/bmme.1997.2637  0.88
1997 Song W, Lahiri DK. Melatonin alters the metabolism of the β-amyloid precursor protein in the neuroendocrine cell line PC12 Journal of Molecular Neuroscience. 9: 75-92. PMID 9407389 DOI: 10.1007/BF02736852  0.88
1997 Lahiri DK, Farlow MR, Sambamurti K, Nall C. The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in HeLa cells. Life Sciences. 61: 1985-92. PMID 9366505 DOI: 10.1016/S0024-3205(97)00868-0  0.88
1997 Lahiri DK, Farlow MR, Nurnberger JI, Greig NH. Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures. Annals of the New York Academy of Sciences. 826: 416-21. PMID 9329715 DOI: 10.1111/j.1749-6632.1997.tb48495.x  0.88
1997 Lahiri DK, Zhang A, Nurnberger JI. High-resolution detection of PCR products from a microsatellite marker using a nonradioisotopic technique Biochemical and Molecular Medicine. 60: 70-75. PMID 9066983 DOI: 10.1006/bmme.1996.2558  0.88
1997 Lahiri DK. An upstream regulatory element of human kapp gkne promoter binds a distinct protkin Faseb Journal. 11.  0.88
1996 Farlow MR, Lahiri DK, Poirier J, Davignon J, Hui S. Apolipoprotein E genotype and gender influence response to tacrine therapy. Annals of the New York Academy of Sciences. 802: 101-10. PMID 8993489 DOI: 10.1111/j.1749-6632.1996.tb32603.x  0.88
1996 Lahiri DK, Farlow MR. Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines. Journal of Molecular Neuroscience : Mn. 7: 41-9. PMID 8835781 DOI: 10.1007/BF02736847  0.88
1995 Lahiri DK. Molecular analysis of the promoter region of the gene encoding the beta-amyloid precursor protein Indian Journal of Biochemistry &Amp; Biophysics. 32: 329-335. PMID 8714200  0.88
1995 von Koch CS, Lahiri DK, Mammen AL, Copeland NG, Gilbert DJ, Jenkins NA, Sisodia S. The mouse APLP2 gene. Chromosomal localization and promoter characterization. The Journal of Biological Chemistry. 270: 25475-80. PMID 7592716 DOI: 10.1074/jbc.270.43.25475  0.88
1995 Song W, Lahiri DK. Efficient transfection of DNA by mixing cells in suspension with calcium phosphate Nucleic Acids Research. 23: 3609-3611. PMID 7567479 DOI: 10.1093/nar/23.17.3609  0.88
1995 Lahiri DK, Nall C. Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1 Molecular Brain Research. 32: 233-240. PMID 7500834 DOI: 10.1016/0169-328X(95)00078-7  0.88
1994 Lahiri DK, Davis D, Nurnberger JI. Melatonin-like immunoreactivity in the presence of different chemicals as determined by the radioimmunoassay. Biochemical Medicine and Metabolic Biology. 51: 51-4. PMID 8192916 DOI: 10.1006/bmmb.1994.1006  0.88
1994 Lahiri DK, Lewis S, Farlow MR. Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines. Journal of Neuroscience Research. 37: 777-87. PMID 8046778 DOI: 10.1002/jnr.490370612  0.88
1994 Lahiri DK. Reversibility of the effect of tacrine on the secretion of the β-amyloid precursor protein in cultured cells Neuroscience Letters. 181: 149-152. PMID 7898757 DOI: 10.1016/0304-3940(94)90581-9  0.88
1994 Lahiri DK. Effect of ionophores on the processing of the beta-amyloid precursor protein in different cell lines. Cellular and Molecular Neurobiology. 14: 297-313. PMID 7788640 DOI: 10.1007/BF02088713  0.88
1993 Lahiri DK. The stability of β-amyloid precursor protein in nine different cell types Biochemistry and Molecular Biology International. 29: 849-858. PMID 8508138  0.88
1993 Lahiri DK, Davis D, Adkins M, Nurnberger JI. Factors that influence radioimmunoassay of human plasma melatonin: a modified column procedure to eliminate interference. Biochemical Medicine and Metabolic Biology. 49: 36-50. PMID 8439449 DOI: 10.1006/bmmb.1993.1004  0.88
1993 Lahiri DK, Schnabel B. DNA isolation by a rapid method from human blood samples: Effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality Biochemical Genetics. 31: 321-328. PMID 8274138 DOI: 10.1007/BF00553174  0.88
1992 Lahiri DK, Bye S, Nurnberger JI, Hodes ME, Crisp M. A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested. Journal of Biochemical and Biophysical Methods. 25: 193-205. PMID 1494032 DOI: 10.1016/0165-022X(92)90014-2  0.88
1992 Lahiri DK, Nall C, Farlow MR. The cholinergic agonist carbachol reduces intracellular beta-amyloid precursor protein in PC 12 and C6 cells. Biochemistry International. 28: 853-60. PMID 1288495  0.88
1991 Lahiri DK, Robakis NK. The promoter activity of the gene encoding Alzheimer beta-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences. Brain Research. Molecular Brain Research. 9: 253-7. PMID 1851527 DOI: 10.1016/0169-328X(91)90009-M  0.88
1991 Lahiri DK, Numberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies Nucleic Acids Research. 19: 5444. PMID 1681511 DOI: 10.1093/nar/19.19.5444  0.88
1989 La Fauci G, Lahiri DK, Salton SR, Robakis NK. Characterization of the 5'-end region and the first two exons of the beta-protein precursor gene. Biochemical and Biophysical Research Communications. 159: 297-304. PMID 2538123 DOI: 10.1016/0006-291X(89)92437-6  0.88
1986 Lahiri DK, Thomas JO. A cDNA clone of the hnRNP C proteins and its homology with the single-stranded DNA binding protein UP2 Nucleic Acids Research. 14: 4077-4094. PMID 3754960 DOI: 10.1093/nar/14.10.4077  0.88
1985 Lahiri DK, Thomas JO. The fate of heterogeneous nuclear ribonucleoprotein complexes during mitosis Journal of Biological Chemistry. 260: 598-603. PMID 3965463  0.88
1981 Rai A, Lahiri DK. Subtyping of foot-and-mouth disease virus by the micro-enzyme-labelled immunosorbent assay (MICROELISA) Acta Virologica. 25: 53-56. PMID 6112867  0.88
1981 Rai A, Lahiri DK. A micro-enzyme-labelled immunosorbent assay (MICROELISA) for the detection of foot-and-mouth disease virus antigen and antibody Acta Virologica. 25: 49-52. PMID 6112866  0.88
1980 Lahiri DK, Burma DP. Presence of precursor ribosome in the ribosomal preparation from chloramphenicol-treated Escherichia coli AB301/I05 (RNase III-) Journal of Biosciences. 2: 379-386. DOI: 10.1007/BF02716872  0.88
1980 Lahiri DK, Burma DP. Immunoprecipitation of 70S, 50S and 30S ribosomes of Escherichia coli Journal of Biosciences. 2: 55-61. DOI: 10.1007/BF02703134  0.88
Show low-probability matches.